143
Views
9
CrossRef citations to date
0
Altmetric
Articles

Carbon nanotube prevents the secondary structure formation of amyloid-β trimers: an all-atom molecular dynamics study

, , &
Pages 1189-1195 | Received 31 Jan 2017, Accepted 14 Apr 2017, Published online: 23 May 2017

References

  • Chiti F, Dobson CM. Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem. 2006;75:333–366.10.1146/annurev.biochem.75.101304.123901
  • Pitschke M, Prior R, Haupt M, et al. Detection of single amyloid β-protein aggregates in the cerebrospinal fluid of Alzheimer’s patients by fluorescence correlation spectroscopy. Nat Med. 1998;4:832–834.10.1038/nm0798-832
  • Xiao Y, Ma B, McElheny D, et al. Aβ(1-42) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer’s disease. Nat Struct Mol Biol. 2015;22:499–505.10.1038/nsmb.2991
  • Stefani M, Dobson CM. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J Mol Med. 2003;81:678–699.10.1007/s00109-003-0464-5
  • Jana MK, Cappai R, Pham CL, et al. Membrane-bound tetramer and trimer Aβ oligomeric species correlate with toxicity towards cultured neurons. J Neurochem. 2016;136:594–608.10.1111/jnc.2016.136.issue-3
  • Kreutzer AG, Yoo S, Spencer RK, et al. Stabilization, assembly, and toxicity of trimers derived from abeta. J Am Chem Soc. 2017;139:966–975.
  • Takahashi T, Mihara H. Peptide and protein mimetics inhibiting amyloid β-peptide aggregation. Acc Chem Res. 2008;41:1309–1318.10.1021/ar8000475
  • Chen Z, Krause G, Reif B. Structure and orientation of peptide inhibitors bound to beta-amyloid fibrils. J Mol Biol. 2005;354:760–776.10.1016/j.jmb.2005.09.055
  • Bieschke J, Russ J, Friedrich RP, et al. EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity. Proc Nat Acad Sci. 2010;107:7710–7715.10.1073/pnas.0910723107
  • Sun Y, Xi W, Wei G. Atomic-level study of the effects of O4 molecules on the structural properties of protofibrillar Aβ trimer: β-sheet stabilization, salt bridge protection, and binding mechanism. J Phys Chem B. 2015;119:2786–2794.10.1021/jp508122t
  • Linse S, Cabaleiro-Lago C, Xue WF, et al. Nucleation of protein fibrillation by nanoparticles. Proc Nat Acad Sci. 2007;104:8691–8696.10.1073/pnas.0701250104
  • Xie L, Luo Y, Lin D, et al. The molecular mechanism of fullerene-inhibited aggregation of Alzheimer’s beta-amyloid peptide fragment. Nanoscale. 2014;6:9752–9762.
  • Wang X, Weber JK, Liu L, et al. A novel form of β-strand assembly observed in Aβ 33-42 adsorbed onto graphene. Nanoscale. 2015;7:15341–15348.10.1039/C5NR00555H
  • Sun Y, Qian Z, Wei G. The inhibitory mechanism of a fullerene derivative against amyloid-β peptide aggregation: an atomistic simulation study. Phys Chem Chem Phys. 2016;18:12582–12591.10.1039/C6CP01014H
  • Zhang T, Zhang J, Derreumaux P, et al. Molecular mechanism of the inhibition of EGCG on the Alzheimer Aβ 1-42 dimer. J Phys Chem B. 2013;117:3993–4002.10.1021/jp312573y
  • Li H, Luo Y, Derreumaux P, et al. Carbon nanotube inhibits the formation of β-sheet-rich oligomers of the Alzheimer’s amyloid-β(16-22) peptide. Biophys J. 2011;101:2267–2276.10.1016/j.bpj.2011.09.046
  • Xie L, Lin D, Luo Y, et al. Effects of hydroxylated carbon nanotubes on the aggregation of Aβ16-22 peptides: a combined simulation and experimental study. Biophys J. 2014;107:1930–1938.10.1016/j.bpj.2014.08.034
  • Fu Z, Luo Y, Derreumaux P, et al. Induced β-barrel formation of the Alzheimer’s Aβ25-35 oligomers on carbon nanotube surfaces: implication for amyloid fibril inhibition. Biophys J. 2009;97:1795–1803.10.1016/j.bpj.2009.07.014
  • Crescenzi O, Tomaselli S, Guerrini R, et al. Solution structure of the Alzheimer amyloid β-peptide (1-42) in an apolar microenvironment. Eur J Biochem. 2002;269:5642–5648.10.1046/j.1432-1033.2002.03271.x
  • Berendsen HJC, Postma JPM, Gunsteren WFV, Hermans J. Interaction Models for Water in Relation to Protein Hydration; Dordrecht, The Netherlands: D. Reidel Publishing, 1981; p. 331–342.
  • Hess B, Kutzner C, van der Spoel D, et al. GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theory Comput. 2008;4:435–447.10.1021/ct700301q
  • Van Gunsteren WF, Billeter SR, Eising AA, Hünenberger PH, Krüger P, Mark AE, Scott WR, Tironi IG. Biomolecular Simulation: The Gromos96 Manual and User Guide; Vdf Hochschulverland. ETH: Zurich, Switzerland; 1996.
  • Bussi G, Donadio D, Parrinello M. Canonical sampling through velocity rescaling. J Chem Phys. 2007;126:014101.10.1063/1.2408420
  • Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph. 1996;14:33–38, 27–28.
  • Kabsch W, Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers. 1983;22:2577–2637.10.1002/(ISSN)1097-0282
  • Azriel R, Gazit E. Analysis of the minimal amyloid-forming fragment of the islet amyloid polypeptide: an experimental support for the key role of the phenylalanine residue in amyloid formation. J Biol Chem. 2001;276:34156–34161.10.1074/jbc.M102883200
  • Wang Q, Yu X, Patal K, et al. Tanshinones inhibit amyloid aggregation by amyloid-β peptide, disaggregate amyloid fibrils, and protect cultured cells. ACS Chem Neurosci. 2013;4:1004–1015.10.1021/cn400051e
  • Gazit E. A possible role for pi-stacking in the self-assembly of amyloid fibrils. FASEB J. 2002;16:77–83.10.1096/fj.01-0442hyp
  • Makin OS, Atkins E, Sikorski P, et al. Molecular basis for amyloid fibril formation and stability. Proc Nat Acad Sci. 2005;102:315–320.10.1073/pnas.0406847102
  • Ma B, Nussinov R. Stabilities and conformations of Alzheimer’s -amyloid peptide oligomers (A 16-22, A 16-35, and A 10-35): Sequence effects. Proc Nat Acad Sci. 2002;99:14126–14131.10.1073/pnas.212206899
  • Mukherjee S, Chowdhury P, Gai F. Effect of dehydration on the aggregation kinetics of two amyloid peptides. J Phys Chem B. 2009;113:531–535.10.1021/jp809817s

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.